Toxicologic Pathology (TPX) is dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge, techniques, and guidelines to enhance the understanding and practice of toxicologic pathology. It is the official journal of the Society of Toxicologic Pathology, the British Society of Toxicological Pathology and the European Society of Toxicologic Pathology, publishing Original Research Articles, Symposium Articles, Review Articles, Meeting Reports, New Techniques, and Position Papers that are relevant to toxicologic pathology. Relevant topics include:

Reports using modern toxicologic pathology methods on the safety assessment of pharmaceuticals, chemicals, food additives, pesticides, environmentally relevant chemicals, and medical devices
Risk characterization of xenobiotics
In vitro and in vivo investigative studies that contribute to refinement of the safety assessment process
Mechanistic studies that provide a basis for interpreting and predicting toxicologic outcome
Novel methods and updated regulatory guidance which advance the practice of toxicologic pathology
Spontaneous diseases that may influence toxicology studies, and animal and alternative models relevant to the practice of toxicologic pathology
Out of scope topics include:

Studies of botanicals and their extracts unless appropriate characterization of the components and concentration of active ingredients is provided (crude extracts will not be accepted)
Studies which endorse or promote a chemoprevention or a therapeutic intervention of a toxicity will not be accepted
This journal is a member of the Committee on Publication Ethics (COPE).

Editor in Chief
Susan A. Elmore, MS, DVM, DACVP, DABT, FIATP    Research Triangle Park, NC, USA
Managing & Production Editor
Stephanie Dickinson, BA, CAE     Toxicologic Pathology Editorial Office, NJ, USA
Illustrations Editor/Cover Design
Beth Mahler   Experimental Pathology Labs, NC, USA
Associate Editors
Bindu Bennet, BVSc, AH, MS, PhD      Janssen Research and Development, Spring House, PA, USA
Catherine Botteron, DVM, PhD, DECVP     Bracco Suisse SA, Switzerland
Molly Boyle, DVM, MPH, DACVP, FIATP    Envigo, Thousand Oaks, CA, USA
Sundeep Chandra, BVSc, PhD, DACVPBVSc, DACVP Biomarin, San Rafael, CA, USA
Darlene Dixon, DVM, PhD, DACVP, FIATP  NIEHS, USA
Stacey Fossey, DVM, PhD, DACVP, FIATP  AbbVie, Chicago, IL, USA
Peter Hall, BVetMed, MRCVS, PhD, FRCPath    UCB Pharma Ltd., Berkshire, UK
Adam Hargreaves, FRCPath, DACVP  PathCelerate Ltd., Cheshire, UK
Mark Hoenerhoff, DVM, PhD, DACVP, FIATP    University of Michigan, Ann Arbor, MI, USA
Kevin Keane, DVM, PhD, FIATP   Novo Nordisk Research Centre, Copenhagen, Denmark
George Parker, DVM, PhD, DACVP, DABT, FIATP     Charles River Laboratories, Durham, NC, USA
Daniel Rudmann, DVM, PhD, DACVP Flagship Biosciences, Westminter, CO, USA
Rain Sellers, DVM, PhD, DACVP  Pfizer Inc., Pearl River, NY, USA
Jerrold M. Ward, DVM, PhD, FIATP    Global Vet Pathology, Montgomery Village, MD, USA
Senior Advisors
John R. Foster, BSc, PhD, DipRCPath. FRCPath, FIATP      ToxPath Sciences Ltd., UK
James Klaunig, PhD, FIATP   Indiana University School of Medicine, USA
Abraham Nyska, DVM, PhD, FIATP     Sackler School of Medicine, Tel Aviv University, Timrat, Israel
Editorial Board
Hibret A. Adissu, DVM, MSc, DVSc, PhD, DACVP     NIH/NCI, Bethesda, MD, USA
Shirley Aguirre, DVM, PhD   Virchow ToxPath, LLC, Prescott, AZ, USA
Duane Belote, DVM, DACVP       Covance Laboratories Inc., Chantilly, VA, USA
Lisa Berman-Booty, VMD, PhD, DACVP     Bristol-Myers Squibb, New Brunswick, NJ, USA
Brian Berridge, DVM, PhD, DACVP     NIEHS, Raleigh, NC, USA
Brad Blakenship, DVM, DACVP   Covance, Madison, WI, USA
Rogely Boyce, DVM, PhD, DACVP      Amgen Inc., Clay, WV, USA
Cory Brayton, DVM, ACLAM, DACVP  Johns Hopkins University School of Medicine, Baltimore, MD, USA
Danielle Brown, DVM, MS, DACVP, FIATP  Charles River Laboratories, Durham, NC, USA
Russ Cattley, VMD, PhD, FIATP   Auburn University, Auburn, AL, USA
Ronnie Chamanza, BVSc, MSc, Dip RC Path, FRCPath, MRCVS      Johnson & Johnson, Huntingdon, UK
Franck Chanut, DVM, MSc, DECVP, DESV-AP   Sanofi, Paris, France
Alan Y. Chiang, PhD     Eli Lilly & Company, Indianapolis, IN, USA
Shambhunath Choudhary, BVSc, PhD, DACVP  Charles River Laboratories, Spencerville, OH, USA
Mark Cline, DVM, PhD, DACVP, FIATP       Wake Forest School of Medicine, Winston-Salem, NC, USA
Samuel M. Cohen, MD, PhD, FIATP   University of Nebraska Medical Center, Omaha, NE, USA
Michelle C. Cora, DVM, DACVP   NIEHS, Research Triangle Park, NC, USA
Diane Creasy, PhD, FRCPath Diane Creasy Consulting, Diss, UK
Kevin Donnelly, DVM, PhD  Theravance Inc., San Francisco, CA, USA
Michael R. Elwell, DVM, PhD, FIATP    Covance Laboratories Inc., Vienna, VA, USA
Jeffrey Everitt, DVM, DACVP, DACLAM, FIATP  Duke University School of Medicine, Durham, NC, USA
Jurgen Funk, Dr. Med. Vet.  Hoffman-LaRoche, Basel, Switzerland
Kathleen A. Funk, DVM, PhD, DACVP Experimental Pathology Laboratories Inc., Sterling, VA, USA
Santokh Gill, PhD  Health Canada, Ottawa, Canada
Katheryn Gropp, DVM, PhD, DACVP  Pfizer Inc., Groton, CT, USA
Silvia Guionaud, PhD, DECVP      AstraZeneca, Cambridge, UK
Jerry Hardisty, DVM, FIATP  EPL Inc., Research Triangle Park, Morrisville, NC, USA
Johannes Harleman, DVM, PhD, ERT, FIATP      Global Preclinical Development & Management GMCRA, Darmstadt, Germany
Wanda M. Haschek-Hock, BVSc, PhD, DACVP, DABT, FIATP   University of Illinois, Urbana, IL, USA
Armando Irizarry, DVM, PhD, DACVP Eli Lilly & Company, Indianapolis, IN, USA
Kyathanahalli Janardhan, BVSc, MVSc, PhD, DACVP Integrated Laboratory Systems, Research Triangle Park, NC, USA
Takahito Kambara, BVSc, MVSc, PhD, FRCPath AbbVie Inc., North Chicago, IL, USA
Ramesh Kovi, BVSc & AH, MVSc, PhD, DACVP, DABT     EPL Inc./NIEHS, Research Triangle Park, NC, USA
Jean-Francis Lafond, DVM, MsC, DES, DACVP  Charles River Laboratories, Quebec, Canada
Sandra McBride, PhD   Social & Scientific Systems, Durham, NC, USA
Elizabeth McInnes, BVSc, PhD, FRCPath, MRCVS, FIATP (Podcast Manager)       Gribbles Healthscope, Guildford, UK
James Morrison, DVM, DACVP    Charles River Laboratories Pathology, Durham, NC, USA
Leslie Ann Obert, DVM, PhD, DACVP GlaxoSmithKline, Collegeville, PA, USA
Ricardo Ochoa, DVM, PhD, DACVP, FIATP Pre-Clinical Safety Inc., Niantic, CT, USA
Arun Pandiri, BVSc&AH, MS, PhD, DACVP NIEHS, Research Triangle Park, NC, USA
Daniel Patrick, DVM, DACVP, DABT    MPI Research, Mattawan, MI, USA
Shyamal D. Peddada, PhD   University of Pittsburgh, Pittsburgh, PA, USA
Giovanni Pellegrini, DVM, PhD, DECVP      AstraZeneca, Gothenburg, Sweden
Jerry Rehg, DVM   St. Jude Children's Research Hospital, Memphis, TN, USA
Amera K. Remick, DVM, DACVP, DABT      Charles River Laboratories, Durham, NC, USA
Roger Renne, DVM, DACVP Roger Renne ToxPath Consulting, Richland, WA, USA
Matthias Rinke, DVM, FIATP Wuelfrath, Germany
Susanne Rittinghausen, DVM, Dr. Med. Vet. Habil.  Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany
Frederic Schorsch, DVM, Msc Tox Path, DESV Ana-Path, DECVP   Bayer CropScience, Antipolis, France
Keith R. Shockley, PhD NIEHS/NIH, Research Triangle Park, NC, USA
Kanaka Tatikola, MS     Johnson & Johnson, Bridgewater, NJ, USA
Reginald A. Valdez, DVM, MS, PhD, DACVP      Amgen, Cambridge, MA, USA
Justin Vidal, DVM, PhD GlaxoSmithKline, King of Prussia, PA, USA
Matthew Wheeler, PhD CDC/NIOSH, Cincinnati, OH, USA
Jeff Wolf, DVM, DACVP Experimental Pathology Laboratories Inc., Sterling, VA, USA
Charles Wood, DVM, PhD, DACVP     Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA